The Department of Health and Human Services is canceling the development of 22 mRNA vaccines, citing a lack of efficacy for preventing respiratory viruses like the flu and COVID-19.

The department issued a press release late Tuesday announcing a “coordinated wind-down” of mRNA vaccine development under the Biomedical Advanced Research and Development Authority, or BARDA. 

Recommended Stories

NIH starts $500 million project for universal flu vaccine

Bird flu makes step in evolving toward human spread

Most Americans not getting COVID-19 booster this fall, survey says